vs
Side-by-side financial comparison of Celanese Corp (CE) and DaVita (DVA). Click either name above to swap in a different company.
DaVita is the larger business by last-quarter revenue ($3.6B vs $2.2B, roughly 1.6× Celanese Corp). DaVita runs the higher net margin — 6.5% vs 0.6%, a 5.8% gap on every dollar of revenue. On growth, DaVita posted the faster year-over-year revenue change (12.3% vs -7.0%). Over the past eight quarters, DaVita's revenue compounded faster (6.6% CAGR vs -8.1%).
Celanese Corporation, formerly known as Hoechst Celanese, is an American technology and specialty materials company headquartered in Irving, Texas. It is a Fortune 500 corporation. The company is the world's leading producer of acetic acid, producing about 1.95 million tonnes per year, representing approximately 20% of global production. Celanese is also the world's largest producer of vinyl acetate monomer (VAM).
DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
CE vs DVA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.2B | $3.6B |
| Net Profit | $14.0M | $234.2M |
| Gross Margin | 19.1% | — |
| Operating Margin | 4.0% | 15.5% |
| Net Margin | 0.6% | 6.5% |
| Revenue YoY | -7.0% | 12.3% |
| Net Profit YoY | 100.7% | 43.8% |
| EPS (diluted) | $0.13 | $3.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $3.6B | ||
| Q4 25 | $2.2B | $3.6B | ||
| Q3 25 | $2.4B | $3.4B | ||
| Q2 25 | $2.5B | $3.4B | ||
| Q1 25 | $2.4B | $3.2B | ||
| Q4 24 | $2.4B | $3.3B | ||
| Q3 24 | $2.6B | $3.3B | ||
| Q2 24 | $2.7B | $3.2B |
| Q1 26 | — | $234.2M | ||
| Q4 25 | $14.0M | $234.2M | ||
| Q3 25 | $-1.4B | $150.3M | ||
| Q2 25 | $199.0M | $199.3M | ||
| Q1 25 | $-21.0M | $162.9M | ||
| Q4 24 | $-1.9B | $259.3M | ||
| Q3 24 | $116.0M | $214.7M | ||
| Q2 24 | $155.0M | $222.7M |
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | — | ||
| Q3 25 | 21.5% | — | ||
| Q2 25 | 21.1% | — | ||
| Q1 25 | 19.9% | — | ||
| Q4 24 | 22.7% | — | ||
| Q3 24 | 23.5% | — | ||
| Q2 24 | 24.2% | — |
| Q1 26 | — | 15.5% | ||
| Q4 25 | 4.0% | 15.5% | ||
| Q3 25 | -52.7% | 14.8% | ||
| Q2 25 | 9.2% | 15.9% | ||
| Q1 25 | 7.0% | 13.6% | ||
| Q4 24 | -59.3% | 17.2% | ||
| Q3 24 | 9.4% | 16.4% | ||
| Q2 24 | 9.4% | 15.9% |
| Q1 26 | — | 6.5% | ||
| Q4 25 | 0.6% | 6.5% | ||
| Q3 25 | -56.1% | 4.4% | ||
| Q2 25 | 7.9% | 5.9% | ||
| Q1 25 | -0.9% | 5.1% | ||
| Q4 24 | -80.8% | 7.9% | ||
| Q3 24 | 4.4% | 6.6% | ||
| Q2 24 | 5.8% | 7.0% |
| Q1 26 | — | $3.22 | ||
| Q4 25 | $0.13 | $3.22 | ||
| Q3 25 | $-12.39 | $2.04 | ||
| Q2 25 | $1.81 | $2.58 | ||
| Q1 25 | $-0.19 | $2.00 | ||
| Q4 24 | $-17.50 | $3.08 | ||
| Q3 24 | $1.06 | $2.50 | ||
| Q2 24 | $1.41 | $2.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $700.7M |
| Total DebtLower is stronger | $11.4B | $10.2B |
| Stockholders' EquityBook value | $4.0B | $-651.1M |
| Total Assets | $21.7B | $17.5B |
| Debt / EquityLower = less leverage | 2.81× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $700.7M | ||
| Q4 25 | — | $700.7M | ||
| Q3 25 | — | $736.5M | ||
| Q2 25 | — | $739.4M | ||
| Q1 25 | — | $511.9M | ||
| Q4 24 | — | $846.0M | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $437.2M |
| Q1 26 | — | $10.2B | ||
| Q4 25 | $11.4B | $10.2B | ||
| Q3 25 | $11.7B | $10.2B | ||
| Q2 25 | $12.7B | $10.1B | ||
| Q1 25 | $12.4B | $9.6B | ||
| Q4 24 | $11.1B | $9.2B | ||
| Q3 24 | $11.3B | $9.3B | ||
| Q2 24 | $11.1B | $8.5B |
| Q1 26 | — | $-651.1M | ||
| Q4 25 | $4.0B | $-651.1M | ||
| Q3 25 | $4.0B | $-571.9M | ||
| Q2 25 | $5.3B | $-369.6M | ||
| Q1 25 | $5.2B | $-267.1M | ||
| Q4 24 | $5.2B | $121.1M | ||
| Q3 24 | $7.3B | $386.7M | ||
| Q2 24 | $7.2B | $632.9M |
| Q1 26 | — | $17.5B | ||
| Q4 25 | $21.7B | $17.5B | ||
| Q3 25 | $22.2B | $17.6B | ||
| Q2 25 | $23.7B | $17.5B | ||
| Q1 25 | $23.2B | $17.1B | ||
| Q4 24 | $22.9B | $17.3B | ||
| Q3 24 | $25.9B | $17.5B | ||
| Q2 24 | $25.8B | $17.0B |
| Q1 26 | — | — | ||
| Q4 25 | 2.81× | — | ||
| Q3 25 | 2.95× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 2.39× | — | ||
| Q4 24 | 2.14× | 75.76× | ||
| Q3 24 | 1.56× | 23.95× | ||
| Q2 24 | 1.54× | 13.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $252.0M | — |
| Free Cash FlowOCF − Capex | $168.0M | — |
| FCF MarginFCF / Revenue | 7.6% | — |
| Capex IntensityCapex / Revenue | 3.8% | — |
| Cash ConversionOCF / Net Profit | 18.00× | — |
| TTM Free Cash FlowTrailing 4 quarters | $803.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $252.0M | $540.7M | ||
| Q3 25 | $447.0M | $841.5M | ||
| Q2 25 | $410.0M | $324.2M | ||
| Q1 25 | $37.0M | $180.0M | ||
| Q4 24 | $494.0M | $547.6M | ||
| Q3 24 | $79.0M | $810.4M | ||
| Q2 24 | $292.0M | $798.8M |
| Q1 26 | — | — | ||
| Q4 25 | $168.0M | $395.3M | ||
| Q3 25 | $383.0M | $675.4M | ||
| Q2 25 | $317.0M | $203.1M | ||
| Q1 25 | $-65.0M | $36.8M | ||
| Q4 24 | $389.0M | $377.0M | ||
| Q3 24 | $-9.0M | $671.4M | ||
| Q2 24 | $187.0M | $674.1M |
| Q1 26 | — | — | ||
| Q4 25 | 7.6% | 10.9% | ||
| Q3 25 | 15.8% | 19.7% | ||
| Q2 25 | 12.5% | 6.0% | ||
| Q1 25 | -2.7% | 1.1% | ||
| Q4 24 | 16.4% | 11.4% | ||
| Q3 24 | -0.3% | 20.6% | ||
| Q2 24 | 7.1% | 21.2% |
| Q1 26 | — | — | ||
| Q4 25 | 3.8% | 4.0% | ||
| Q3 25 | 2.6% | 4.9% | ||
| Q2 25 | 3.7% | 3.6% | ||
| Q1 25 | 4.3% | 4.4% | ||
| Q4 24 | 4.4% | 5.2% | ||
| Q3 24 | 3.3% | 4.3% | ||
| Q2 24 | 4.0% | 3.9% |
| Q1 26 | — | — | ||
| Q4 25 | 18.00× | 2.31× | ||
| Q3 25 | — | 5.60× | ||
| Q2 25 | 2.06× | 1.63× | ||
| Q1 25 | — | 1.10× | ||
| Q4 24 | — | 2.11× | ||
| Q3 24 | 0.68× | 3.77× | ||
| Q2 24 | 1.88× | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CE
| Engineered Materials | $1.3B | 58% |
| Acetyl Chain | $940.0M | 43% |
DVA
Segment breakdown not available.
